VarCov Co’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$202K Sell
692
-123
-15% -$40.7K 0.1% 316
2026
Q2
$273K Buy
+815
New +$258K 0.1% 290

Other funds holding PRAX

VarCov Co's PRAX Position: Q3 2026 in Review

VarCov Co reduced its Praxis Precision Medicines (PRAX) stake by 15% in Q3 2026, selling an estimated $40.7K and leaving 692 shares worth $202K. The position accounts for 0.1% of the portfolio, ranked #316.

VarCov Co first reported a position in PRAX in Q2 2026 and has held it in 2 quarters since. The position peaked at $273K in Q2 2026. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • VarCov Co held 692 shares of Praxis Precision Medicines worth $202K as of Q3 2026.
  • VarCov Co sold 123 Praxis Precision Medicines shares in Q3 2026, an estimated $40.7K.
  • Praxis Precision Medicines made up 0.1% of VarCov Co's portfolio in Q3 2026, its #316 holding.
  • VarCov Co first reported a position in Praxis Precision Medicines in Q2 2026 and has held it in 2 quarters since.
  • VarCov Co's Praxis Precision Medicines position peaked at $273K in Q2 2026.
  • 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.